The R&D pipeline reflects our long-term commitment to driving change to defeat obesity, haemophilia, growth disorders and other serious chronic diseases
Scientific articles authored by Novo Nordisk scientists
Facts and figures specific to our Research & Development organisation
How we report our financial, social and environmental performance
What guides the way we do business
How we contribute to the Sustainable Development Goals
Explore features and points of view from Novo Nordisk
and the society we serve
Lotte Bjerre Knudsen tells how she turned an “underdog project” into a treatment for millions of people with diabetes and obesity.
Listen to the podcast
Novo Nordisk Chief science officer Mads Krogsgaard Thomsen reflects on the past, present and future of insulin in a tablet.
Read the story
President and chief executive officer of Novo Nordisk, Lars Fruergaard Jørgensen on why the definition of obesity is just the beginning of a broader, more significant discussion.
On World Heart Day, our colleague Simone spoke openly about her type 2 diabetes and cardiovascular disease.
We have set an ambitious target of converting all our global production sites to 100% renewable power by 2020.
With millions displaced by war, business has a key role in helping refugees integrate, contribute and flourish in society.
Can your peers help prevent type 2 diabetes? Henriette Curtz Jansen from Copenhagen municipality thinks so and shares how peer networks have been successful in Denmark.
See all articles